Researchers focused on the global challenge posed by multidrug-resistant (MDR) bacteria, particularly in healthcare settings, investigating the use of fecal microbiota transplantation (FMT) as a strategy against recurrent Clostridioides difficile infections and its impact on other microbiota-related diseases. The results showed a reduction in MDR bacteria colonization post-FMT, with an 11.5% decrease in the colonization rate of MDR bacteria.
Reference: Nooij S, Vendrik KEW, Zwittink RD, et al. Long-term beneficial effect of faecal microbiota transplantation on colonisation of multidrug-resistant bacteria and resistome abundance in patients with recurrent Clostridioides difficile infection. Genome Med. 2024 Feb 28;16(1):37. doi: 10.1186/s13073-024-01306-7. PMID: 38419010; PMCID: PMC10902993.
